These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37093598)

  • 1. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants.
    Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
    JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy Number Variation and Clinical Outcomes in Patients With Germline PTEN Mutations.
    Yehia L; Seyfi M; Niestroj LM; Padmanabhan R; Ni Y; Frazier TW; Lal D; Eng C
    JAMA Netw Open; 2020 Jan; 3(1):e1920415. PubMed ID: 32003824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
    Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
    J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
    Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F;
    J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime cancer risks in individuals with germline PTEN mutations.
    Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
    Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome.
    Hendricks LAJ; Hoogerbrugge N; Mensenkamp AR; Brunet J; Lleuger-Pujol R; Høberg-Vetti H; Tveit Haavind M; Innella G; Turchetti D; Aretz S; Spier I; Tischkowitz M; Jahn A; Links TP; Olderode-Berends MJW; Blatnik A; Leter EM; Evans DG; Woodward ER; Steinke-Lange V; Anastasiadou VC; Colas C; Villy MC; Benusiglio PR; Gerasimenko A; Barili V; Branchaud M; Houdayer C; Tesi B; Yazicioglu MO; van der Post RS; Schuurs-Hoeijmakers JHM; ; Vos JR
    J Natl Cancer Inst; 2023 Jan; 115(1):93-103. PubMed ID: 36171661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome.
    Smith JR; Liu E; Church AJ; Asch E; Cherella CE; Srivastava S; Kamihara J; Wassner AJ
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1121-e1130. PubMed ID: 33347563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome.
    Mester JL; Zhou M; Prescott N; Eng C
    Urology; 2012 May; 79(5):1187.e1-7. PubMed ID: 22381246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
    Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
    Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
    Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
    PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications for Germline PTEN Spectrum Disorders.
    Ngeow J; Sesock K; Eng C
    Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the neurological features of individuals with germline PTEN variants: A multicenter study.
    Dhawan A; Baitamouni S; Liu D; Busch R; Klaas P; Frazier TW; Srivastava S; Parikh S; Hsich GE; Friedman NR; Ritter DM; Hardan AY; Martinez-Agosto JA; Sahin M; Eng C
    Ann Clin Transl Neurol; 2024 May; 11(5):1301-1309. PubMed ID: 38501559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome.
    Smith JR; Marqusee E; Webb S; Nose V; Fishman SJ; Shamberger RC; Frates MC; Huang SA
    J Clin Endocrinol Metab; 2011 Jan; 96(1):34-7. PubMed ID: 20962022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
    Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Progression of Thyroid Disease in
    Plitt G; Brewer T; Yehia L; Jin J; Shin J; Eng C
    Thyroid; 2022 Sep; 32(9):1094-1100. PubMed ID: 35761794
    [No Abstract]   [Full Text] [Related]  

  • 17. Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.
    Hendricks LAJ; Hoogerbrugge N; Venselaar H; Aretz S; Spier I; Legius E; Brems H; de Putter R; Claes KBM; Evans DG; Woodward ER; Genuardi M; Brugnoletti F; van Ierland Y; Dijke K; Tham E; Tesi B; Schuurs-Hoeijmakers JHM; Branchaud M; Salvador H; Jahn A; Schnaiter S; Anastasiadou VC; Brunet J; Oliveira C; Roht L; Blatnik A; Irmejs A; ; Mensenkamp AR; Vos JR
    Eur J Med Genet; 2022 Dec; 65(12):104632. PubMed ID: 36270489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review on age-related cancer risks in PTEN hamartoma tumor syndrome.
    Hendricks LAJ; Hoogerbrugge N; Schuurs-Hoeijmakers JHM; Vos JR
    Clin Genet; 2021 Feb; 99(2):219-225. PubMed ID: 33140411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with PTEN hamartoma tumor syndrome.
    Liu D; Yehia L; Dhawan A; Ni Y; Eng C
    Cell Rep Med; 2024 Feb; 5(2):101384. PubMed ID: 38242121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer.
    Shiovitz S; Everett J; Huang SC; Orloff MS; Eng C; Gruber SB
    Breast Cancer Res Treat; 2010 Nov; 124(2):459-65. PubMed ID: 20349131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.